Cardiopulmonary exercise testing (CPET) appears to have potential utility in the noninvasive detection of systemic sclerosis (SSc)-associated pulmonary arterial hypertension (PAH), with a new study suggesting that the method may particularly reduce unnecessary right heart catheterisation (RHC) procedures.
The new tool to identify cases of systemic autoimmune rheumatic diseases (SARD) has shown sensibility and validity, according to a recent study, adding that the use of both screening and confirmatory questions improves its accuracy.
Single-nucleotide polymorphisms (SNP) associated with rheumatoid arthritis (RA), as a group, are not related with coronary artery disease (CAD), according to a new study.
The intra-articular steroid preparation methylprednisolone acetate is as effective as triamcinolone acetonide in the treatment of chronic inflammatory arthritis, according to the results of a trial.
Erectile dysfunction may potentially be associated with gout, a new systematic report and meta-analysis reveals. However, the low quality and high degree of heterogeneity among the studies included reduce the certainty of this conclusion.
The rates of herpes zoster (HZ) vaccination may significantly improve with the electronic identification of vaccine eligibility and best practice alert (BPA), according to a quality improvement project based on the pre- and postintervention design.
Despite having no adverse effect, there is no evidence supporting the efficacy of teriparatide for healing fractures, a new meta-analysis reports. However, more high-quality studies are needed to yield more definitive conclusions about its effectiveness.
Use of tocilizumab—through the intravenous or subcutaneous route and either as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs—carries a low risk of immunogenicity in rheumatoid arthritis, a study has shown.
The risk of sleep disturbances may be higher among patients with rheumatoid arthritis (RA) than among individuals without the disorder, a recent study suggests.
Adequately administered biological therapies, with proper follow-up, do not increase the risk for cancer development in patients with psoriatic arthritis (PsA), an observational study confirms.